GAD2 and Alzheimer disease: At the molecular level, our results showed transgenic alteration of SAP102 in both sexes, but a dysregulation of GAD65 only in transgenic females, suggesting that females could be more susceptible to an AD-related inhibitory synaptic dysregulation.